Issue 25, 2024

Synthesis of the monomeric counterpart of Marinomycin A and B

Abstract

The synthesis of polyketide natural products has been a captivating pursuit in organic chemistry, with a particular focus on selectively introducing 1,3-polyol units. Among these natural products, Marinomycins A–D have garnered substantial interest due to their exceptional structural features and potent cytotoxicity. In this paper, we present a novel approach for synthesising the monomeric counterparts of Marinomycin A and B. Our method employs a previously established iterative cycle in conjunction with a standardised polyketide building block. Through this strategy, we showcase a promising pathway towards total and partial syntheses of these intriguing natural products.

Graphical abstract: Synthesis of the monomeric counterpart of Marinomycin A and B

Supplementary files

Article information

Article type
Paper
Submitted
07 May 2024
Accepted
28 May 2024
First published
07 Jun 2024
This article is Open Access
Creative Commons BY license

Org. Biomol. Chem., 2024,22, 5127-5133

Synthesis of the monomeric counterpart of Marinomycin A and B

F. Ballaschk, K. Bensberg, B. Crone, S. F. Kirsch and H. Menz, Org. Biomol. Chem., 2024, 22, 5127 DOI: 10.1039/D4OB00742E

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements